Indonesian President Joko Widodo has received the first dose of a Chinese-made vaccine as part of the launch of the country’s ambitious Read more
Health
The Indonesian food and drug monitoring agency yesterday issued emergency authorisation for the coronavirus vaccine developed by China’s Sinovac Biotech after it was found to be 65.3 per cent effective in a local clinical trial.
The breathalyser was developed by scientists at Gadjah Mada University in Jogjakarta, in central Java, where three hospitals are already using it to screen patients for COVID-19.
Jakarta returns to full large-scale social restrictions (PSBB) on Monday as the central government plans broader Java-Bali restrictions amid the increasing number of COVID-19 cases.
A successful COVID-19 vaccination drive could help the government reach its target of reducing the budget deficit to under 3 percent in three years, a state official has said. “The government target could be reached by controlling and reducing coronavirus cases,” Regional Representatives Council (DPD) speaker La Nyalla Mattalitti said in a written statement on Wednesday.
“Doom surfing” is a term used to describe those who seem unable to remove themselves from scrolling the internet, and “infodemic” another, a term adopted by the WHO for the misinformation that appears to spread online faster than the virus itself.
Indonesia’s big bet on a Chinese vaccine could give its trillion-dollar economy a head start on the road to recovery next year – as long as the jab works.
As South-East Asia’s economies have contracted and slowed, there have been serious concerns for food security in the region.
Indonesian police held firebrand Muslim leader Rizieq Shihab for questioning on suspicion of breaching coronavirus restrictions by staging several mass gatherings.
The government will prioritise Java and Bali islands for the first round of vaccination programs due to their high number of COVID-19 cases.
With its first shipment of China’s experimental CoronaVac vaccine arriving this week, Indonesia still faces a mammoth task to combat the continuing surge in infections from the coronavirus.
The vaccines that can be used in Indonesia must come from local pharmaceutical company PT Bio Farma, United Kingdom-based AstraZeneca, China’s Sinopharm Read more
UGM epidemiologist, Bayu Satria Wiratama, revealed that the decision to start face-to-face learning needs to involve a number of parties, including the Education Office, the Health Office, and also epidemiologists.
In Indonesia, pressure is building for authorities to get coronavirus vaccines to 270 million people living on 17,000 islands in its vast archipelago. Few countries are relying more fervently on Covid-19 vaccines to blunt the pandemic than Indonesia.
The world is facing unprecedented challenges due to the economic, health and social costs of the global COVID-19 pandemic.
Indonesia reached a new milestone in daily number of coronavirus cases after adding 6,267 new cases on Sunday, the third time it broke its own daily record during the past week alone.
